Non-interventional (observational) post-licensure study to assess the effectiveness and safety of recombinant zoster vaccine in adults aged =18 years with psoriasis or psoriatic arthritis (EPI-ZOSTER-045 VE US 216976)

20/10/2023
06/09/2024
EU PAS number:
EUPAS107230
Study
Ongoing
Documents
Study protocol
Initial protocol
English (1.65 MB - PDF) View document
Study results
Study report
Other information